O

Ondine Biomedical Inc
LSE:OBI

Watchlist Manager
Ondine Biomedical Inc
LSE:OBI
Watchlist
Price: 10.25 GBX Market Closed
Market Cap: 53.1m GBX

Wall Street
Price Targets

OBI Price Targets Summary
Ondine Biomedical Inc

There are no price targets for OBI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Ondine Biomedical Inc Competitors:
Price Targets
ACARIX
Acarix AB
38% Upside
688575
Shenzhen YHLO Biotech Co Ltd
29% Upside
AORT
Artivion Inc
16% Upside
6699
Angelalign Technology Inc
43% Upside
NMTC
Neuroone Medical Technologies Corp
243% Upside
ABT
Abbott Laboratories
14% Upside
CVRX
CVRx Inc
43% Upside
AHC
Austco Healthcare Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
Ondine Biomedical Inc

For the last 3 years the compound annual growth rate for Ondine Biomedical Inc's revenue is -7%. The projected CAGR for the next 3 years is 161%.

-7%
Past Growth
161%
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Ondine Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Ondine Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OBI's stock price target?
Not Available

OBI doesn't have any price targets made by Wall Street professionals.

What is Ondine Biomedical Inc's Revenue forecast?
Projected CAGR
161%

For the last 3 years the compound annual growth rate for Ondine Biomedical Inc's revenue is -7%. The projected CAGR for the next 3 years is 161%.

Back to Top